Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Organon Mid-Europe (France, Belgium, Luxemburg, Switzerland) France, Belgium, Luxemburg, Switzerland. One Team for better & healthier every day for every woman. Organon, here for her health We are a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established brands across a wide array of conditions and diseases. For more information, visit www.organon.fr or follow us on https://twitter.com/OrganonFrance Type: Startup Activities: healthtech Technologies: Synthetic Biology | 10 | 3 | 8 | 113 | |
XenTech Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years. XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets. patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assays Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 2 | 4 | 37 | |
Syndivia Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy. Drug development, Biotechnology, Pharmaceuticals, Antibody-drug conjugates, DAR1 ADC, and ADC Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 3 | 0 | 5 | |
Elveflow Microfluidics | an Elvesys brand Microfluidic premium instrumentation & solutions for all 👉 https://www.elveflow.com World leader in premium microfluidic instrumentation. Proven track record delivering systems for the best institutions worlwide. Elvesys captures the spark of smart ideas to give life to innovative concepts that will iIlluminate the world. We stand for innovation, quality, performance, fun and a sense of competitive challenge. Elvesys was built on a strong entrepreneurial spirit and founded on the belief that microfluidics will change the world. This is why in the recent years, Elvesys has spawned a number of innovative companies from microfluidics innovations: -Elveflow: Elveflow focuses on the development of … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 14 | 2 | 11 | 32 | |
Stilla Technologies Discover the Sensitivity & Simplicity of Multiplex Crystal Digital PCRTM Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla’s next-generation Multiplex Crystal Digital PCRTM technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world's first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 5 | 7 | 100 | |
Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 2 | |
Dynocardia, Inc. Enlightened blood-pressure management Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrackTM, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events. Biomedical, cardiovascular, cNIBP, … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 0 | 20 | |
NordicInfu Care AB Nordic Infucare started its journey as an entrepreneurial company with the desire to do things differently. Mats Bergryd founded the business to offer specialized treatments in a home environment, serving patients who suffer from chronic disease. He chose that niche as he, after 20 years in the industry, had identified a gap between what was possible to achieve with smart technology and pharmaceuticals, and the actual results. Mats concluded that there was an opportunity to increase the quality of life for patients with chronic disease by closing the gap, and that it would be good business for the one who … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 135 | |
Eurofins Viracor Get results faster, when it matters most. It’s so much more than a specimen. It's a life. With over 30 years of specialized expertise in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critical patients, Eurofins Viracor is committed to helping medical professionals, transplant teams, reference labs and biopharmaceutical companies get results faster, when it matters most. Eurofins Viracor is passionate about providing timely, actionable test results, never losing sight of the connection between the testing we perform and the patients our results ultimately serve. Find out more by visiting us at www.eurofins-viracor.com/clinical Eurofins Viracor is an equal … Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 268 | |
Bumble Bee Foods The Bumble Bee Seafood Company is on a mission to create a new generation of seafood lovers. The Bumble Bee Seafood Company is passionately pursuing its purpose of feeding people’s lives through the power of the ocean. The iconic 120-year-old fishing company consistently aims to deliver delicious, healthy and affordable food to consumers while working hard to find new ways to protect the ocean and those that rely on it. Bumble Bee is firmly anchored in a commitment to connect the world to the ocean by re-defining sourcing, producing and enjoying products from and inspired by the ocean. Bumble Bee’s … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 2 | 2 | 303 | |
miRecule, Inc. RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality. Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology Data Analytics | 2 | 2 | 1 | 19 | |
Invenio THINK. MAKE. PROTECT. Founded by healthcare industry professionals with decades of global surgical product experience, Invenio provides a full range of services and solutions for assisting in infection prevention and control. Our vast portfolio of products and capabilities allows us to work with our clientele to tailor products and programs that meet their exacting requirements. Whether the needs are for procedure packs and components, minor kits, or packaging services, our vertically integrated manufacturing provides options for on-shore, near-shore, and far shore to support supply chain resiliency and compliance requirements. Our years of clinical expertise will assist us with selecting the … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 27 | |
Amgen Deutschland [Automatic translation follows] Our mission: to help patients. We use biotechnology to treat serious diseases. Amgen was founded in 1980 and is now a leading global independent biotechnology company with around 27,000 employees in almost 100 countries. As a pioneer in biotechnology, we at Amgen have over four decades of experience in the research, development and production of innovative human therapeutics. We focus on diseases for which there are few or no treatment options. Millions of patients with serious illnesses worldwide benefit from our therapies every year. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health and chronic … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 9 | 1 | 6 | 90 | |
Bulk Pharmaceuticals Task Force An industry trade organization for manufacturers of active pharmaceutical ingredients, intermediates and excipients. The Bulk Pharmaceuticals Task Force (BPTF) is an industry trade organization representing manufacturers of active pharmaceutical ingredients, intermediates and excipients. BPTF addresses regulatory and plant operations issues related to current Good Manufacturing Practices compliance. BPTF establishes sound working relationships with regulators, allied industries and the public and serves as a reliable source for the development and implementation of balanced regulations and industry guidance resources. BPTF undertakes this advocacy on behalf of its member companies to achieve drug product and drug substance supply chain safety for consumers. Type: SMB Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 4 | 0 | 4 | 2 | |
Avadel Pharmaceuticals PLC Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. We are disrupting paradigms where it’s needed most – starting with narcolepsy. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. At Avadel, our core values foster an atmosphere of transformation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with sleep disorders. Learn more … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 3 | 0 | 2 | 204 | |
Don Whitley Scientific Ltd The leading international supplier to the microbiology and tissue culture industries Don Whitley Scientific is a leading international supplier of innovative equipment and services to the microbiology and tissue culture industries. We develop, manufacture, market and service instrumentation and associated products for the public and private sector - primarily for use in hospitals, public health laboratories, food testing organisations and research institutions. We now have the largest, most comprehensive range of workstations specifically designed for the study of anaerobes and microaerophiles. Automated microbiology and cell culture equipment, Contract microbiology laboratory, and Service and maintenance contracts Type: SMB Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 2 | 0 | 1 | 55 | |
BIOTEM First Class Antibodies & Immunoassays Your partner in immunotechnologies since 1980! Our commitment makes the difference! Expert in immunotechnology, BIOTEM is a contract Research Organisation which complies with ISO 9001:2008 quality standards. Since its establishment in 1980, the company has been the privileged partner of prestigious industrial and academic laboratories for their R&D, diagnostic and therapeutic projects. Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project and is pledged to achieve the results outlined in the contract. BIOTEM advantages: - Results guaranteed - An unparalleled traceability throughout your project - Optimal quality of your product … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 17 | 4 | 15 | 42 | |
ALIOS Conseil - ALIOS recrute!! [Automatic translation follows] ALIOS Conseil is a CRO created in 1995 and specialized in providing experts to the health industries (Pharmaceutical, Medical Device and Cosmetic) Our consulting offer is structured around our 5 departments: Clinical Research, Health Product Vigilance, Medical Affairs, Regulatory Affairs and Quality Assurance. Our objective: meet your needs and support you on your issues ALIOS CONSEIL is: - A tailor-made, fast and efficient response - Motivated, experienced and supported employees throughout their intervention - Transparency for our customers and employees Contact: Website: www.aliosconseil.com Email: aliosconseil@aliosconseil.com Tel. : 07 88 81 64 52 Provision of employees, Management Consulting, … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 4 | |
Didactic - Medical Devices Act for Care For more that 50 years, Didactic makes work life easier for professional healthcare. Expert in manufacturing, sterilization, distribution and commercialization of medical devices class I and II CE, we act for better healthcare for the benefit of patients, healthcare professionals and caregivers. Type: SMB Activities: healthtech Technologies: Synthetic Biology | 4 | 4 | 0 | 96 | |
MicroPort CRM Connecting Everyone for Healthier Hearts MicroPort Scientific Corporation is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, MicroPort maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Endovascular, Neurovascular, Electrophysiology, Surgical Management, Diabetes Care and Endocrinal Management, and others. MicroPort is committed to its vision of being a patient oriented global enterprise, improving and reshaping patient lives through … Type: Large company SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 601 | |
Orphan Quantum Your Scientific and Regulatory Consultant for Pharmaceuticals | Medical Devices | Medical Innovation As a new player in the world of consulting for the pharmaceutical and medical device industries, ORPHAN QUANTUM is dedicated to supporting Manufacturers, Biotech, and Pharma in the fields of scientific affairs, regulatory matters, and clinical domains. As an independent consultant specialized in Health R&D, I position myself as an alternative to traditional consulting solutions through my approach. I offer customized support for the development of your innovations and accompany you from the initial interactions, allowing for the quick and precise identification of your needs to propose … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 1 | |
TAGC Understanding biological complexity, from genotype to phenotype, with interdisciplinary approaches. Our laboratory is a joint research unit of INSERM and the University of Aix-Marseille. We seek to decipher the complex biological mechanisms involved in the development or physiological functioning of an organism. Our research project is organized around two axes, one entitled "bioinformatics and genomics of molecular networks", the second "genetics and genomics of multifactorial diseases". We conduct not only basic research projects, but also collaborative projects with hospitals and biotech companies. This policy is fully in line with INSERM's strategic plan. Our ambition is both to contribute to a … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 13 | |
PROTOMED SA Contract medical device development in cardiovascular and minimally invasive surgery. Thanks to the experience and global vision that we bring to the development projects of minimally invasive surgery and cardiovascular devices, we propose a global project architecture offering the key to success to the bearers. By creating favorable conditions for innovation, especially through the animation of a multidisciplinary hub of specialists, we help to advance care and their consequences with rigor and creativity. We are committed alongside our clients to bring their vision and ambition to life. R&D, design, medical device, testing, manufacturing, regulatory compliance, cardiovascular, and minimally invasive Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 1 | 0 | 14 | |
PMSm [Automatic translation follows] Medical assistance in the workplace / Outsourcing of company nurses / Biomedical engineering A French leader in medical assistance in industrial and tertiary environments, PmSm is a structure dedicated to providing medical services. * Outsourcing of company nurses * Emergency medical assistance: sites open to the public, construction sites, technical shutdowns, industrial sites, medical centers in isolated environments or in hostile environmental conditions; etc. * Support for drug and alcohol prevention policies * Biomedical engineering (supply and maintenance of medical devices) PmSm recruits nurses and doctors on permanent contracts who are seconded to client companies. It offers … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 12 | 1 | 11 | 275 | |
Biose Industrie Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 5 | 3 | 222 | |
Anthogyr French creator of cutting-edge implantology solutions. About ANTHOGYR With more than 75 years of industrial expertise and experience in the dental industry, Anthogyr designs and manufactures ingenious and accessible solutions in implantology and customised prostheses for dentistes and dental laboratories. Recognised for its high quality products, Anthogyr offers the following: - implants system Axiom® Multi Level®, screw retained tooth AxIN® - customized prosthesis (digital & CAD/CAM solutions Simeda®, Initial®, guided surgery) - equipment for implantology and surgery Mont Blanc® - implantology trainings, CAMPUS Anthogyr - patient communication tools - Serenity® warranty program Both innovative and reactive, Anthogyr assists implantologists in … Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 5 | 2 | 5 | 250 | |
Vexim is now a part of Stryker Based in Balma, near Toulouse (France), Vexim is a medical device company created in February 2006. The Company has specialized in the creation and marketing of minimally-invasive solutions for treating traumatic spinal pathologies. Benefitting from the financial support of it longstanding shareholder, Truffle Capital and from OSEO public subsidies, Vexim has designed and developed the SpineJack®, an implant for the reduction of mobile spinal fractures and restoration of the balance of the spinal column. The Company currently has 65 members on its staff and it has its own sales teams in France, Germany, Austria, Italy, Spain, as well as distributors … Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 10 | |
Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 31 | 6 | 27 | 376 | |
Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … Type: SMB Activities: biotech Technologies: Synthetic Biology | 9 | 3 | 7 | 123 | |
ELICITYL Glycans & Glycoconjugates expertise Elicityl is a biotechnology company based near Grenoble France within one of the largest research clusters in Glycosciences in the world. 👉🏻 Elicityl is specialized in carbohydrates design & manufacturing and has unique expertise in extraction, purification, bacterial fermentation, characterization, and analysis of carbohydrates. Our catalog of products, which is constantly evolving, includes: ✅ 200 glycans involved in key biological pathways (Cell adhesion, Immunological recognition, Embryogenesis, Oncogenesis, Infection...) ✅ Analytical references (HMOs, Malto-Oligosaccharides, Fructo-Oligosaccharides...) ✅ Polysaccharides extracted from biomass (Alginate, Ulvan, Pustulan...) ✅ Functionalized glycans ✅ Glycoconjugates ✅ Lectins We supply materials from the mg scale … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 4 | 1 | 3 | 16 | |
GENCLIS SA The Transcription Infidelity Technology GENCLIS SA is a privately-held French Biotechnology that discovered a unique biological mechanism referred as to Transcription Infidelity (TI). Transcription Infidelity is a newly discovered and patented mechanism that incresases RNA-DNA sequence divergences (RDD). TI can lead to base substitutions, insertions and deletions. The latter cause translational frameshifts that have important consequences in determining protein immunogenicity. Genclis currently focuses on defining the effects of TI proteins translated from gapped RNA on normal and pathological humoral immunity. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 7 | 5 | 2 | 155 | |
Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
SYNCROSOME - Cardiovascular Preclinical expert Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services. At a glimpse SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years. Range of services SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available. Our added value We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 1 | 9 | |
Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 6 | 2 | 4 | 4 | |
BioFeyn BioFeyn is a life sciences company, pioneering advancements in nutrient, medicine, and vaccine delivery to improve food systems and sustainability. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 0 | 5 | 3 | |
Dermadry Laboratories inc. Creators of the anti-sweat device. Dermadry is the world's leading manufacturer of iontophoresis machines for the treatment of hyperhidrosis, a medical condition characterized by excessive sweating that affects approximately 1 in 20 people worldwide. We offer three tailored solutions to treat the three areas most commonly affected by hyperhidrosis: the hands, feet, and underarms. Our Canadian-made range of iontophoresis machines include the Dermadry Hands & Feet, Dermadry Underarms, and the all-in-one Dermadry Total. Our FDA cleared and CE marked iontophoresis machines are an effective and non-invasive way to treat excessive sweating from the comfort and privacy of your home. During … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
Drug and Alcohol Testing Institute (DAT Institute) Promote educational opportunities, advance "best practices," and benchmarking opportunities for DER's. Program Managers, Promoting a drug and alcohol-free workplace by advancing professionalism through quality education and best practices. Education, Networking, Regulatory Compliance, Drug Testing, Alcohol Testing, Safety, and Human Resources Type: Startup Activities: entertainment Technologies: Synthetic Biology | 2 | 0 | 2 | 1 | |
Cellulis Automation and standardization of cryopreservation processes for Cell Therapies Cellulis (formerly ZF Biotox) provides disruptive cryopreservation technologies in a broad range of biotechnology fields aiming to innovate CELL THERAPY solutions, to streamline BIOPROCESSING production, to enhance BIOBANKING and to improve High Throughput Screening (HTS) campaigns. Frozen Cells in Microplates Ready to Use., Final product formulation for cryopreserved cell therapy, and Cryopreservation of Cell Therapies Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Biosantech [Automatic translation follows] TO DATE, THE MOST ADVANCED THERAPEUTIC VACCINE AGAINST AIDS IN THE WORLD BIOSANTECH, created in April 2011 by Roger and Corinne TREGER is an innovative company with a NORTH / SOUTH equitable vocation based in Sophia Antipolis Valbonne in the Provence-Alpes Cote d'Azur region. BIOSANTECH aims to promote and develop an effective vaccine on all variants of the AIDS virus. BIOSANTECH has an exclusive cooperation agreement with the CNRS and the University of Aix Marseille and owns the exclusive license to valorize and market the vaccine patents from the "TAT Oyi". BIOSANTECH, currently has the only therapeutic … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 7 | |
Spiderwort Inc. Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 20 | |
DTU Health Tech Technology for human health and well-being We develop health technology that makes life better for people. DTU Health Tech educates the engineers of the future, and develop new technology and solutions with a vision to improve people's life before, during and after they are patients. We do this in close collaboration with the health sector, industry, academia and other health partners, because we believe that the best results and ideas often occur in a close collaboration between different sectors. Health technology, Bioinformatics, Biomimetics, Biotherapeutic engineering, Digital health, Drug delivery, Immunology, Hearing research, Magnetic resonance, Medical isotopes, Dosimetry, Optical sensing, Ultrasound, … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 0 | 3 | 159 | |
Clarity Make brain health accessible to everyone, everywhere. Clarity leverages light and sound to pioneer a new category of therapeutics for neurological conditions. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 2 | 5 | 25 | |
3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an ambitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 14 | |
Akari Therapeutics, Plc Developing novel advanced therapies to address unmet needs of patients with autoimmune & inflammatory diseases. Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA and orphan drug designation … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Cellply Unravelling immune system function, one cell at a time Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 0 | 0 | 0 | 35 | |
Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 19 | |
Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 2 | 3 | 51 | |
MedTrace Pharma A/S We innovate medical imaging to help health care professionals diagnose patients better and faster. MedTrace is striving to minimize diagnostic uncertainty through better perfusion imaging. Perfusion imaging provides medical professionals with a functional understanding of the organs blood supply inside the patient. MedTrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly. Our solution allows for absolute blood flow quantification based upon the PET tracer 15O-water, which has long been acknowledged as the gold standard tracer for non-invasive blood flow quantification. Our innovative solution is intended to making 15O-water practically available right next to … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 45 | |
AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 2 | 0 | 16 | |
Pathios Therapeutics Using human genetics to transform cancer outcomes Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases. Our clinical-stage oncology programme leverages cutting-edge proprietary genetic insights, transcriptomics, and functional immunology of GPR65 as a key immune cell sensor of acidosis in multiple pathological environments, to bring about a revolutionary new approach to treating a broad spectrum of cancers. We are also building an emerging pipeline in neuroinflammatory and neurodegenerative disorders leveraging the broader immunological roles of this receptor in cell types such … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 20 | |
Synamics Therapeutics AI-Driven Drug Discovery to Combat Drug Resistance in Cancer - Member of NVIDIA Inception Program At Synamics Therapeutics, our innovative strategy is not just about treating cancer—it's about staying one step ahead. The heart of our approach lies in our advanced AI-driven resistance modeling. This allows us to not only confront existing cancer mutations but also to proactively anticipate and target potential future mutations. By predicting these future resistance pathways, our AI model guides the design of our small molecules to effectively combat evolving cancer threats. This forward-thinking approach ensures the sustained efficacy of our therapies, significantly enhancing patient outcomes … Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 4 | 0 | 3 | 8 | |
TOLREMO therapeutics Stopping non-genetic cancer drug resistance as it emerges TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments. By stopping cancer drug resistance as it emerges, we aim to surmount a universal challenge for current and future targeted therapies for lasting patient benefit. Drug Discovery, Drug Development, Cancer Drug … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 14 | |
SOLID Therapeutics An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 9 | |
HHC medical Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 34 | |
OKYO Pharma OKYO focuses on novel GPCR based therapeutics for eye diseases of unmet need and non-opioid analgesics for chronic pain. OKYO Pharma focuses on: A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis. An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 0 | 8 | |
Mikrobiomik rethinking microbiome Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 23 | |
Bastion Therapeutics Creating a future where inflammatory disorders are curable Bastion Therapeutics is a preclinical stage biotech with a mission to develop novel Treg cell therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRITTM platform technology to engineer Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg cell therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 0 | 5 | 7 | |
BioLamina Cell-specific culture matrices for improved cell functionality BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety of applications, including the reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types. Our chemically defined and xeno-free laminin cell culture matrices allow you to imitate the natural cell-matrix interaction in vitro. Laminins are key components of the extracellular matrix. Through their interactions with specific receptors, laminins trigger the authentic cellular responses, pivotal for cell anchorage, survival, proliferation, migration, organization, … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 113 | |
AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh. AlveoGene has secured an exclusive licence to a proprietary and validated … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 3 | |
Broken String Biosciences Turning breaks into breakthroughs Broken String Bioscience’s technology platform, INDUCE-seq®, supports the development of cell and gene therapies that are safer by design.INDUCE-seq®, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS | 2 | 0 | 1 | 42 | |
Galactica Biotech Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 0 | 0 | 0 | 1 | |
Akamis Bio Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer. Akamis’ growing pipeline of T-SIGn® therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 2 | 3 | 49 | |
Carisma Therapeutics Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 3 | 83 | |
Platinum Discovery Multiomics research for precision medicines Platinum Discovery offers a cutting-edge Tumour-to-Target Platform, specialising in cancer vaccine development through the identification of tumour-specific neoantigens. We provide a comprehensive, end-to-end drug discovery pipeline, supporting clinical trial research and translational science for patient samples. Our multidisciplinary team brings together expertise in biology, clinical sciences, multi-omics technologies, bioinformatics, and computational sciences, enabling a deep understanding of the biological processes critical to drug development. We excel at integrating diverse scientific domains to deliver holistic, innovative solutions. With extensive experience in designing and managing complex research programmes, we assemble tailored teams of experts, drawing on our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Koniku Bio is TechTM At Koniku Inc., we take the view that a biological neuron is a *material*. An intelligent material or component to be utilized in real life products or devices. Clearly, this proposition opens up a unique set of technology challenges, solvable. It simultaneously offers up an unimaginably vast trove of opportunities. Opportunities ranging from pure-play neurotech, *living devices* to advanced brain-machine interfaces. Koniku is the worlds first corporation of its kind. We are the leading brand in neurotechnology devices. Our goal is to harness the "raw" biological basis of intelligence. Our maxim is: “Bio is TechTM”. We are … Type: Startup Activities: biotech deeptech Technologies: Affective Computing New Materials Synthetic Biology | 9 | 3 | 6 | 4 | |
Vortex Biosciences Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have entered the patient bloodstream. These CTCs are known to be the key cause of secondary tumors in patients. As a result, the number and type of CTCs in a patient blood is highly indicative of the status of cancer in that patient. CTCs provide insight into the source of the primary tumor, grade, invasiveness, response to therapy and recurrence. As an indication, approximately 1.5 million new cancer patients are diagnosed per year in the United States, and around 20 million existing patients are undergoing … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 6 | |
Sesame Pay half. Be whole. Sesame is building a radically new healthcare system for uninsured Americans and those with high-deductible plans. The company's marketplace replaces historically inefficient, expensive healthcare with a direct connection – either virtually or in-person – between patients and physicians. This direct connection enables Sesame to offer doctor visits, labs, imaging and prescription drugs at half the price. Founders include a Harvard PhD in health policy and economics; a former Goldman Sachs analyst; and entertainment executive and healthcare reformer David Goldhill, author of the legendary cover story in The Atlantic, "How American Health Care Killed My Father." Sesame … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 7 | 2 | 6 | 137 | |
Multus Feeding food. 🔵 What do we do? Multus is reinventing growth media for cell culture in cultivated meat and life science. From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain. 🔵 How do we do it better? We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up. 🔵 Why do we do it? Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone. To … Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology | 16 | 3 | 11 | 28 | |
Vetbiobank Leading Animal Cell Therapy - Improving Animal Healthcare. Vetbiobank is a biotech company specialized in veterinary regenerative medicine. For our customers and their animal companions (dogs, cats, horses), we are leveraging the unique biological potential of neonatal stem cells. Those stem cells deliver locally an appropriate set of bioactive messages to organise and promote the harmonious healing of injuries or dampen inflammatory chronic diseases. Funded in 2011, Vetbiobank has built its expertise on the experience of its founder, former expert in human cell therapy development, and cord blood derived stem cells. The mission of Vetbiobank is to provide veterinarians with … Type: Startup Activities: pettech biotech deeptech Technologies: Synthetic Biology | 5 | 2 | 3 | 10 | |
Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 1 | 114 | |
Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 6 | |
NEOSTEO SIMPLE CREATIVE SOLUTIONS NEOSTEO is a smart innovative startup company specialized in the development, production and marketing of advanced implants solutions aimed to simplify orthopedic and trauma surgery. With over 15 years of experience and a state of the art production line, NEOSTEO’s team offer a comprehensive range of Knee Osteotomy Implants Solutions as well as a wide range of solutions for Forefoot surgery. The company's products are being distributed around Europe countries through its experimented global distribution network. NEOSTEO' Surgeons Advisory Board and engineers are committed to continuous research and development of new progressive products and technologies to support … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 4 | |
TERRAMIE [Automatic translation follows] Terramie is the specialist in the creation of therapeutic gardens and gardens of life, throughout France. Our advisors support healthcare establishments and their teams in the creation of tailor-made gardens, adapted to structures and pathologies. For a sustainable and vibrant living space, we also support caregivers in specific training on the Garden tool. Because the garden is known for its benefits on everyone's well-being, the Terramie team is committed to sharing its knowledge, with the help of healthcare professionals, always in accordance with our ethics. Our charter is based on: - Respect for the person - Adapting … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 1 | |
SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 16 | 5 | 13 | 20 | |
IHU LIRYC - Heart rhythm disease Institute 🔬 Liryc is an international research, clinical and teaching centre focusing on heart rhythm diseases. The Heart Rhythm Disease Institute (French: L'Institut des maladies du RYthme Cardiaque), is one of 6 French university hospital institutions created in 2011 as part of the investments in the future program ("Investissements d'avenir") to boost medical research and innovation. This institute, created by Professor Michel Haissaguerre along with cardiology teams of the University Hospital of Bordeaux, unites multiple specialties around cardiac electrophysiology from research on ionic channels (microgenerators producing electric flows in cells) to whole heart and patient care. LIRYC is a basic research, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 29 | 9 | 7 | 107 | |
MDoloris Medical Systems Our technology help clinicians titrating analgesics to control surgical stress, and improve outcomes in both OR and ICU MDoloris Medical Systems is a young innovative start-up (ISO 9001 and ISO 13485 certified) created in June 2010 to leverage more than 23 years of academic research conducted at the University Hospital of Lille. Our mission is to provide clinicians with the means to efficiently, continuously and non-invasively asses patient pain and comfort. The goal is to personalize pain therapy, in order to avoid known adverse effects of over- or underdosage of those drugs. Our technology is ideal when patients are unable … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 11 | 9 | 0 | 34 | |
Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: Startup Activities: healthtech biotech Technologies: A.I. Synthetic Biology | 46 | 12 | 23 | 58 | |
Alrena Technologies [Automatic translation follows] Teleconsult from white zones and medical deserts Alrena Technologies is a startup created in 2015 by an emergency physician and a radiocommunications specialist, both concerned about the expansion of medical deserts and the extent of digital deserts in France. Together, they developed transmission solutions (mobile and secure) capable of covering the white zones of the territory. They then coupled them with portable and interoperable medical devices allowing the performance, in the field, of para-clinical examinations. (the healthcare professional can use his own medical devices, as long as they are connectable). The results obtained are transmitted in real … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 3 | 1 | 2 | 4 | |
LYSOGENE Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early … Type: Startup Activities: biotech deeptech kidtech Technologies: Synthetic Biology | 8 | 6 | 0 | 10 | |
Remma [Automatic translation follows] 1st marketplace for used medical devices for professionals. 1st marketplace specializing in the sale and reconditioning of used medical devices for healthcare professionals. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 10 | |
INOPROD 🇫🇷🇨🇭 [Automatic translation follows] Expertise and 4.0 technology at the service of your industrial performance! Inoprod – Consulting, Expertise & Engineering. Inoprod provides assistance to SMEs for the innovation of their products and processes. Inoprod mainly operates in three areas of activity: - Product development. From the idea to industrialization, the successful development of a product requires a methodical and structured organization. Based on industrially recognized tools, Inoprod supports its clients in their approach. - Optimization of products and processes. Profitability, the watchword of any manager. In order to increase it, Inoprod provides solutions via simulation: o The sizing of mechanical … Type: Startup Activities: industry 4.0 Technologies: Synthetic Biology | 24 | 3 | 8 | 31 | |
Eurosafe CRO [Automatic translation follows] Eurosafe is a Good Laboratory Practice (GLP) certified contract research company (CRO), specializing in human and veterinary pharmaceutical products, cosmetic products (ingredients and finished products), food supplements and medical devices. Depending on your products, a single contact, surrounded by scientists and regulatory experts, will assist you in defining and carrying out the regulatory procedures, carrying out the ADME (Absorption, Distribution, Metabolism and Elimination), safety, tolerance or efficacy tests required for marketing your products. Eurosafe is a unique CRO with multiple skills, organized around 3 complementary areas: - In vitro tests - Tests on volunteers - Toxicological and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 5 | 18 | |
DOQBOARD We help healthcare actors develop their knowledge by facilitating collaboration in observational Research 🎯 DOQBOARD is a collaborative & investigator-centric eCRF platform dedicated to observational Research. It allows researchers, healthcare facilities, research groups, and healthcare industries to develop their knowledge by conducting studies and registries more simply and efficiently. DOQBOARD platform is GDPR compliant and hosted in France 🇫🇷 in an ISO27001 environment certified for health data hosting. 🔒 To know more, visit our website at https://www.doqboard.com or contact us at contact@doqboard.com. Recherche clinique, Études cliniques, Cohortes, Registres, Thèses de médecine, Bases de données cliniques, eCRF, Observational research, Real world … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Vet'eau [Automatic translation follows] Created in 2007, Vet’eau is a veterinary practice recognized for its expertise in the aquaculture sector in France and abroad. Our activity covers all areas of aquaculture: freshwater fish farming, marine farming, ornamental fish, etc. Our team is made up of specialized veterinarians, engineers and laboratory technicians as well as an administrative center in direct contact with customers. Present in more than 15 countries, we offer several multidisciplinary services: laboratory analysis, health management and biosecurity, etc. Aquaculture, Laboratory analysis, Health management, Biosecurity, Health prophylaxis, Veterinary products, Veterinary equipment, Freshwater fish farming, Marine farming, Ornamental fish, Shellfish, Research … Type: Startup Activities: pettech it services Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
PhaBuilder An leading synthetic biotechnology company focusing on the green manufacturing of biodegradable plastic PHAs. PhaBuilder is a company with leading synthetic biotechnology, focusing on the transformation and engineering of halophilic microorganisms. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 4 | 2 | 4 | 17 | |
SwitchESS Cell-wise driving SWITCHESS is a leader in electricity storage solutions for stationary applications based on the switched cell principle. Compared to current solutions, our technology combines safety, balancing and power conversion through real-time control of each cell in the pack. The result is an increase of more than 10% in roundtrip efficiency, a 15% improvement in service life and absolute safety. batteries, BMS, and Conversion de puissance Type: Startup Activities: deeptech Technologies: Synthetic Biology Batteries | 1 | 1 | 1 | 4 | |
EOVE Inovative company specialized in the development and manufacture of medical devices EOVE develops and manufactures innovatives products to improve care and quality life with greater freedom for Adult ans Pediatric Patients who suffer from breathing disorders and chronic respiratory diseases. Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 3 | 3 | 0 | 30 | |
SAS IMPROVE IMPROVE an alternative protein CDMO Located in Dury near Amiens, The SAS IMPROVE is The Protein Innovation Center fully dedicated to alternative source of proteins. We produce and study nutritious and functionnal protein ingredients for food, feed and cosmetic applications. IMPROVE provide a high level of expertise from fundamental research to market knowledge. Industrial experience, scientific expertise, chemists and biochemists, process ingeneers...With a 800m2 pilot plant and 170m2 of laboratories IMPROVE offers a unique combination of skills and equipment to boost innovation and value generation for: Reducing time to market for new proteins products Enabling breakthrough innovations that meet market’s … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 4 | 0 | 29 | |
Laboratoire ClaripharmTM Laboratoire Claripharm, women healthcare manufacturer Made in 🇫🇷 ClaripharmTM Laboratory has developed an innovative range of products for the care and protection of intimate wounds and sutures. ClaripharmTM created Claricare TM : the first flexible shell for protection of intimate wounds & stitches after a perineal tear or an episiotomy, vulvar and anal galling or condyloma, bartholinitis, labiaplasty, vaginal prolapse, coccyx dislocation, hemorrhoids, anal fissures, intimate cosmetic surgery ... Claricare TM is a patented medical device, CE marked and manufactured in France . ONCE UPON TIME A WOMAN... Giving birth to a child is one of the most intense and … Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 105 | 8 | 93 | 12 | |
Innocress [Automatic translation follows] SUPERCRESS 5: YOUR 100% WATERCRESS FOOD SUPPLEMENT THE NATURAL STRENGTH OF YOUR IMMUNE SYSTEM. A Picardy start-up that focuses on watercress for therapeutic use. Despite its nutritional interest, watercress cultivation is declining in France. To revive it, Innocress has launched into the production of a powder concentrating its therapeutic virtues as a food supplement. Type: Startup Activities: foodtech Technologies: Bio sourced materials Synthetic Biology | 10 | 4 | 7 | 2 | |
Aldebaran [Automatic translation follows] The medical assistant that takes care of doctors and patients. Aldebaran develops a digital medical assistant for healthcare professionals to free up medical time and promote optimal health to as many people as possible. Aldebaran allows patients to securely prepare their consultation using AI questionnaires validated by its medical committee. The doctor then receives a summary in medical language allowing him to better anticipate the patient's health needs. Used today by +200 doctors in France, our medical assistant also helps with screening and primary and secondary prevention (tobacco, alcohol, sports activity, violence, mental health, sleep, etc.) Aldebaran … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 17 | 5 | 15 | 26 | |
BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, and Bioprocess Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials Synthetic Biology | 11 | 6 | 5 | 16 | |
DiogenX Targeting Beta Cell recovery in Diabetes DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world. Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits. DiogenX is headquartered in Marseille, with labs in Nice (France). Biotechnology and Diabetes Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 2 | 3 | 19 | |
PepKon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 6 | 6 | 7 | |
Biofrontera Group We aim to protect and heal your skin with our innovative photodynamic therapy medication. Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 87 | |
ADVANZ PHARMA Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 645 | |
Mainstay Medical First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 143 | |
Codexis, Inc. We deliver exquisite enzymes for the betterment of human health. Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 0 | 9 | 249 |